january 1915

Boghuma Kabisen Titanji was just 8 years old when the hyper-contagious virus swept through her classroom. Days later, she started to feel feverish, and developed a sparse, rosy rash. Three years after being fully dosed with the measles vaccine, one of the most durably effective immunizations in our roster, Titanji fell ill with the very pathogen her shots were designed to prevent.

Her parents rushed her to a pediatrician, worried that her first inoculations had failed to take. But the doctor allayed their fears: “It happens. She’ll be fine.” And she was. Her fever and rash cleared up in just a couple of days; she never sickened anyone else in her family. It was, says Titanji, now an infectious-disease physician and a researcher at Emory University, a textbook case of “modified” measles, a rare post-vaccination illness so mild and unthreatening that it doesn’t even deserve the full measles name.

Updated at 9:28 a.m. on September 21, 2021.

For nearly two years now, Americans have lived with SARS-CoV-2. We know it better than we once did. We know that it can set off both acute and chronic illness, that it spreads best indoors, that masks help block it, that our vaccines are powerful against it. We know that we can live with it—that we’re going to have to live with it—but that it can and will exact a heavy toll.

Still, this virus has the capacity to surprise us, especially if we’re not paying attention. It is changing all the time, a tweak to the genetic code here and there; sometimes, those tweaks add up to new danger. In a matter of weeks, the Delta variant upended the relative peace of America’s early summer and ushered in a new set of calculations about risk, masking, and testing. The pandemic’s endgame shifted.

When Dear Evan Hansen premiered on Broadway in 2016, it drew near-universal praise from New York’s theater critics. Ben Platt, playing an anxious teenager who becomes an internet celebrity after misrepresenting his role in a local tragedy, was showered with plaudits, and the show ended up winning six Tony Awards—the most of the season—including Best Musical and a leading-actor trophy for Platt. A film version was thus hardly a surprise. But when the director Stephen Chbosky’s extremely faithful adaptation premiered as the opening-night movie of this year’s Toronto International Film Festival—the movie will be released in theaters this Friday—the reviews that followed were … broadly bad.

What changed? It wasn’t the story or the songs. Dear Evan Hansen the film is written by Steven Levenson, who wrote the narrative of the Broadway show, and largely retains the score, by Benj Pasek and Justin Paul (a few of the least compelling numbers have been cut; others have been added). And while the cast around Platt is mostly filled out by movie stars rather than Broadway veterans, the performances from actors such as Amy Adams, Julianne Moore, Kaitlyn Dever, and Amandla Stenberg are uniformly solid. Did something get lost in translation, or is this an emperor’s-new-clothes moment revealing that Dear Evan Hansen never was any good in the first place?

Democrats in Congress are divided on a slew of important issues right now, leaving President Joe Biden’s signature $3.5 trillion spending plan in jeopardy. What unites them is the illusion that the way they handle the plan will make or break the party’s fortunes in next year’s midterms.

If only things worked that way. The election is almost certainly a lost cause for Democrats, and, if it’s not, it’s likely out of their control either way. Democrats have power now; the question is whether they will use it while they have it.

The Biden plan has always had a treacherous path to tread, and this week it seems closer than ever to plunging into the abyss. Party leaders in both chambers have insisted on pushing forward, but they face competing pressure from their left and right flanks. House progressives want to vote on both a $1.2 trillion bipartisan infrastructure deal and the $3.5 trillion plan at the same time, but Senator Joe Manchin wants a “strategic pause” on the larger package, perhaps into 2022. Senator Kyrsten Sinema has reportedly told Biden that if the House doesn’t vote on the bipartisan deal or the vote fails, she won’t support the bigger bill. But House moderates are wary of voting on anything without knowing what the Senate will pass.

Conspiracy theorists who discount the safety and efficacy of COVID-19 vaccines and other public-health mandates are often portrayed in the media as right-wing. That’s for good reason: a not-insignificant number of the most vocal conspiracists tie their ideology firmly to President Donald Trump and the right-wing MAGA movement he inspired. Videos of angry red-state demonstrators pushing back against school boards and other local authorities in public hearings, and repeating outlandish, baseless misinformation, have made the rounds in traditional media.

But in the hills of western Massachusetts and in neighboring regions of upstate New York, a traditionally left-leaning area, these theories also hold purchase. I grew up in the region and started my journalistic career there. I’ve been arguing with residents, many of whom are close friends, about vaccines for more than a decade. But despite my efforts, and the efforts of many others, a stubborn resistance to reality has set in here, and only deepened since the pandemic began. Late last month, Do We Need This?, a group of anti-vaxxers and vaccine-mandate opponents, held a “festival” in the region to raise money for their cause, suggesting a $20 donation for entry. They shared the proceeds with other national vaccine-skeptic groups, including NY Stands Up!, the Informed Consent Action Network, and Robert Kennedy Jr.’s Children’s Health Defense.